Milton Park Christmas Market 2019
Thursday 12th December.
There’ll be a wide variety of stalls selling
local produce and handmade gifts. It should be the perfect time to pick up some
Christmas stocking fillers or simply have a browse on your lunch break.
You can also enjoy complimentary mince pies,
pigs in blankets and mulled wine from Café Metro while exploring the stalls.
Head down to the Park Centre (under the white
canopy, next to Café Metro) anytime between 11am and 2pm.
We are running the tombola, proceeds of which comes to the
Sadly, Sue Webb passed away this week. She was only in having physio last Friday. I do not have any further details, I am sure Chris will give me a call soon. Just thought I should let you know. It’s very sad news.
Does anyone have a spare wheelchair, we need a good lightweight one at the centre?
The donation rates are remaining the same for 2020 even though we have not had a good year with regards to fundraising income. We have had no sponsored events at all in 2019. If you or anyone you knows is/or can do a sponsored event for us please do encourage it. If you have any fundraising ideas could you please share them with Gloria or Maggie who have taken on the fundraising role. Membership for 2020, MS Member: £12, non-ms Member: £24. Donation rates remain the same.
|From Multiple Sclerosis News Today|
A single dose of CD45-ADC, an investigational targeted therapy being developed to treat different types of autoimmune diseases, is enough to reset the normal function of the body’s immune system in a mouse model of multiple sclerosis (MS), and to delay onset of the disease. Those findings were presented earlier this week in the poster […]
The post Single Dose of CD45-ADC Resets the Immune System, Delays the Onset of MS in Mice appeared first on Multiple Sclerosis News Today.
Read on Â»
Source MS Society: The Advertising Standards Authority (ASA) has upheld our complaint against the Government’s Universal Credit adverts.
In June, as part of the Disability Benefits Consortium (DBC), we submitted a complaint to the ASA about the DWP’s advertising campaign in the Metro newspaper.
The ads claimed to be a “myth buster” on Universal Credit. But we argued they were misleading and dangerous to the health and financial security of disabled people.
After receiving our complaint, the ASA launched a formal investigation. Read on.
Source MS Trust: Sativex is a cost-effective treatment for people with MS spasticity according to new guidance published today by NICE(link is external). This reverses the decision made in draft guidance published earlier this year.
The guideline recommends that, providing the local NHS health authority is willing to pay for continued treatment, a 4-week trial of Sativex can be offered to people with moderate to severe MS-related spasticity which has not been improved by other treatments. At the end of the trial, if their spasticity-related symptoms have improved by at least 20%, they can continue taking Sativex. Read on.
Source MS Trust: Lemtrada (alemtuzumab) should be restricted to people with highly active relapsing-remitting MS according to a review carried out by the European Medicines Agency’s (EMA) drug safety committee.
Highly active relapsing-remitting MS covers people who continue to have relapses despite taking at least one disease-modifying drug (DMD) or if MS is worsening rapidly with at least two disabling relapses in a year and MRI scans show new MS activity. In addition, Lemtrada must no longer be used in people with certain heart, circulation or bleeding disorders or in people who have auto-immune disorders other than MS.
The recommendations also include new measures to identify and treat problems that may occur after having a Lemtrada infusion. Read on.